Belgium's Omega Pharma considers selling itself: Bloomberg
(Reuters) - Omega Pharma NV [COUCKO.UL], a Belgian healthcare products distributor, is considering selling itself nearly three years after it was taken private by its founder, Bloomberg reported on Monday, citing sources.
A sale of the Nazareth, Belgium-based company could earn its owners more than $4 billion, the news agency quoted a person familiar with the matter as saying. (bloom.bg/1qccu2V)
Omega Pharma could not immediately be reached for a comment.
The company, which sells prescription-free medicines, healthcare products and over-the-counter (OTC) items such as wart treatments and sun tan lotions, was working with investment bank Morgan Stanley (MS.N) on the sale, and the process could start as early as this month, sources told Bloomberg.
Founder and CEO Marc Coucke succeeded in taking the company private in 2011 with his $1.1 billion takeover offer for the maker of painkiller Solpadeine. (reut.rs/1r3x9Yx)
(Reporting by Esha Vaish in Bangalore; Editing by Bernard Orr)
NEW YORK - U.S. stock index futures were slightly lower on Friday, after the latest flare of tensions between Ukraine and Russia and ahead of a speech by Federal Reserve Chair Janet Yellen.
BEIJING/HONG KONG - China reiterated its opposition on Thursday to a European Union plan to limit airline carbon dioxide emissions and called for talks to resolve the issue a day after its major airlines refused to pay any carbon costs under the new law.